Fi-VISION MAC – Biotechnological Supplement Clone

Description

Fi-VISION MAC

Programmato per pazienti con maculopatia (AMD – Age-Related Macular Degeneration o Maculopatia Degenerativa legata all’età)

 

MACULOPATHY

È una patologia degenerativa che colpisce la macula, la regione della retina deputata alla visione distinta, e può comportare gravi compromissioni visive.

I pazienti con familiarità per maculopatie dovrebbero sottoporsi con regolarità a controlli ed esami tra cui test di elettrofisiologia (M-ERG*,F-ERG*): scoprire la malattia in fase precoce ha un notevole impatto sulla prognosi della stessa. In caso di risultati alterati, si raccomanda  l’utilizzo di FI-VISION MAC.

 

WHAT IS IT?

The device (DM) is presented as a thin disk of 26 mm in diameter. It is packaged together with the relative instructions for use and two Tegaderm Film 4.4×4.4cm patches, necessary for its application on the skin. The DM is composed of a support in Polyethylene terephthalate (Mylar) on which an amalgam is layered containing, as main elements, micronized aluminum and fluorescent nanocrystals of graphene called Quantum Dots. The device, in contact with the skin, by potential difference, sends the patient very weak electromagnetic signals capable of inducing biological effects, in particular: reduction of oxidative stress and stabilization of functional parameters at the level of the retina. The DM is registered as a Class I Medical Device, with CE certification according to regulation (EU) 2017/745.

Example of DM application on the wrist.

Please note! The choice of application point is at the discretion of the patient.

 

HOW TO USE

1. The DM is applied to the skin, so that the logo is visible and the satin side is in contact with the skin.

2. The DM is then fixed to the skin with the transparent Tegaderm Film adhesive, supplied in the package: the application points are chosen at the patient's discretion.

3. For best results, it is recommended to keep the DM applied for a period of 30 days.

4. During the period of use of DM, especially during the first week, it is recommended to maintain high levels of hydration.

 

FINAL NOTES

1. DM causes no known side effects;

2. It can be used continuously according to individual needs.

3. It is advisable to monitor, at the end of the first month of application, the parameters of visual function (visual acuity, perimetry, electrofunctional tests).

4. It does not interact with other pharmacological treatments, but is used alongside them.

5. Since the intensity of the electromagnetic field transmitted by the DM is extremely low, it does not interfere with normal cardiac activity, nor with cardiac electrostimulators (pacemakers).